Y.D. More Investments Ltd Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Y.D. More Investments Ltd increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 43.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,821 shares of the healthcare conglomerate’s stock after purchasing an additional 548 shares during the period. Y.D. More Investments Ltd’s holdings in UnitedHealth Group were worth $875,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Chelsea Counsel Co. purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $27,000. 25 LLC purchased a new stake in UnitedHealth Group during the first quarter valued at about $28,000. Cascade Investment Advisors Inc. purchased a new position in shares of UnitedHealth Group in the first quarter worth about $28,000. Freedom Wealth Alliance LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $31,000. Finally, Kalos Management Inc. bought a new position in shares of UnitedHealth Group during the first quarter valued at about $34,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

UNH stock opened at $486.06 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10. The business has a 50 day simple moving average of $492.05 and a two-hundred day simple moving average of $486.73. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80. The company has a market capitalization of $450.24 billion, a price-to-earnings ratio of 21.75, a PEG ratio of 1.43 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, topping the consensus estimate of $5.92 by $0.22. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The business had revenue of $92.90 billion for the quarter, compared to analysts’ expectations of $90.97 billion. During the same quarter in the previous year, the company earned $5.57 EPS. The business’s quarterly revenue was up 15.6% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 24.83 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Monday, September 11th will be paid a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is currently 33.65%.

Insider Buying and Selling

In related news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the sale, the chief executive officer now owns 78,573 shares in the company, valued at approximately $39,772,866.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.35% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research analyst reports. Wells Fargo & Company reduced their target price on UnitedHealth Group from $616.00 to $561.00 in a research note on Thursday, July 13th. Stephens reissued an “overweight” rating and set a $560.00 price objective on shares of UnitedHealth Group in a report on Friday, August 11th. TD Cowen cut their target price on shares of UnitedHealth Group from $562.00 to $555.00 and set an “outperform” rating for the company in a research report on Monday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Thursday, September 14th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $587.00 target price on shares of UnitedHealth Group in a report on Friday, July 14th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $575.65.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.